Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,504 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07774403RecruitingPhase 2
Study of AZD0292 in Chinese patients with bronchiectasis and chronic Pseudomonas infection
This study tests a new medication called AZD0292 for people with bronchiectasis who have a long-term Pseudomonas infection. It aims to see if the drug can reduce flare-ups and improve lung health.
AnyangAges 18 years+ - NCT07773129RecruitingPhase 1
How a new drug is processed in healthy men
This study tests a new drug called ASP3082 to see how the body absorbs, distributes, and removes it. It is for healthy men only and will help researchers understand the drug's behavior before it is tested in patients.
Madison, WisconsinAges 18–65 - NCT07775495Recruiting
Urine light patterns for microplastic exposure
This research study uses photographs of urine samples to explore how microplastics and nanoplastics in the environment might show up in your body. It is observational, meaning you will not receive treatment, but your participation could help scientists better understand everyday plastic exposure.
Birmingham, AlabamaAges 18 years+ - NCT07771465RecruitingPhase 3
Long-term safety of danicamtiv for genetic dilated cardiomyopathy
This study checks the long-term safety and effectiveness of the drug danicamtiv in people with a genetic form of dilated cardiomyopathy, a condition where the heart muscle becomes weak and enlarged. If you've already completed the earlier DAN-301 study, this trial continues to monitor you while you keep taking the medication.
Birmingham, AlabamaAges 18 years+ - NCT07769489RecruitingPhase 1
Comfort study of larger under-the-skin injections
This study checks if giving larger volumes of liquid under the skin (subcutaneous injection) at different speeds is comfortable and acceptable to healthy people. It aims to see how the body reacts to help make future injections more comfortable for patients.
Gentofte MunicipalityAges 18–64 - NCT07774650RecruitingEarly Phase 1
Imaging study of immune activity in healthy volunteers
This study tests a new imaging agent that may help show immune activity in the body using a PET scan. It is being tested in healthy volunteers to see how it behaves and to help plan future studies.
New Haven, ConnecticutAges 18–60 - NCT07770828RecruitingPhase 3
Gene therapy for advanced dry age-related macular degeneration
This trial tests an experimental gene therapy, OCU410, for people with geographic atrophy, an advanced form of dry AMD that causes blind spots in the center of vision. The study aims to see if this treatment can slow down the progression of the disease and help preserve remaining vision.
Phoenix, ArizonaAges 55 years+ - NCT07768189RecruitingPhase 3
Testing CRB-701 for throat cancer that returned
This study tests an investigational drug called CRB-701 to see if it can help people with a certain type of throat cancer that has not responded to standard treatments. The trial compares CRB-701 to a doctor's choice of other available treatments.
Huntsville, AlabamaAges 18 years+ - NCT07770802RecruitingPhase 1
Study of an investigational cell therapy for advanced kidney cancer
This trial tests an investigational medicine called HS-IT101 for people with advanced kidney cancer that hasn't responded to standard treatments. The goal is to see if this new therapy can help shrink or control the cancer.
BeijingAges 18–75 - NCT07768345RecruitingPhase 3
Revaccination with RSV vaccine for immunocompromised adults
This trial studies whether giving a booster dose of the RSV vaccine (Abrysvo) is safe and effective for adults with weakened immune systems. It includes people who have never had an RSV vaccine and those who had one or two doses in the past.
Los Angeles, CaliforniaAges 18 years+ - NCT07775287RecruitingPhase 3
Petosemtamab plus chemotherapy for advanced colorectal cancer
This study tests a new drug called petosemtamab combined with chemotherapy for people with advanced colorectal cancer that has not responded to one prior treatment. The trial aims to see if adding petosemtamab helps the cancer shrink or grow more slowly compared to adding a standard targeted therapy like cetuximab or bevacizumab.
Los Angeles, CaliforniaAges 18 years+ - NCT03787771Recruiting
Fecal transplant registry for donors and recipients
This is a registry that collects information from adults who either receive fecal microbiota transplant (FMT) or plan to receive it, and from people who have donated—or plan to donate—stool for FMT. It helps researchers understand who participates in these gut-microbiome treatments in real life.
Hong KongAges 18 years+ - NCT06221683RecruitingPhase 2
Personalized induction therapy for children with AML based on genetics
This trial tests different induction therapy options based on the specific genetic subtype of a child’s AML and how the leukemia responds early on. The goal is to personalize treatment to improve outcomes and reduce side effects.
Hefei, AnhuiAges Up to 18 years - NCT06561620RecruitingPhase 4
Befotertinib after surgery for early-stage lung cancer
This trial tests a pill called befortinib for people with early-stage lung cancer who have had surgery. It aims to lower the chance of the cancer coming back. You might qualify if your tumor had certain high-risk features and you still have cancer DNA in your blood after surgery.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06569485RecruitingPhase 2
Trilaciclib plus chemo for new DLBCL patients
This study tests whether adding a drug called trilaciclib to standard chemotherapy can help people with newly diagnosed Diffuse Large B-Cell Lymphoma. It aims to see if this combination keeps blood counts healthier and improves treatment outcomes.
Guangzhou, GuangdongAges 18 years+ - NCT07770269Recruiting
Heart function and anesthesia depth during heart surgery
This study checks how well the heart works and how deep the anesthesia is during planned heart surgery where a heart-lung machine is used. It aims to improve safety and outcomes for patients.
ThessalonikiAges 18 years+ - NCT07774520RecruitingPhase 2
Lower dose of lazertinib plus magnesium to prevent nerve damage in advanced lung cancer
This trial tests a lower starting dose of the targeted therapy drug lazertinib combined with magnesium supplements to prevent a common side effect (peripheral neuropathy) in people with advanced lung cancer caused by certain EGFR mutations. The goal is to see if this approach keeps the drug effective while reducing nerve damage symptoms like numbness or tingling.
Seoul, Gang-nam GuAges 19 years+ - NCT07771127Recruiting
Comparing a special pad to a sandbag for groin bleeding after heart procedure
This study compares two ways to stop bleeding after a heart procedure through the groin: using a special pad or a sandbag. It aims to see which method works better and is safer.
Bursa, NilüferAges 18 years+ - NCT07771803RecruitingEarly Phase 1
Soursop tea study for advanced blood cancer
This study tests whether drinking soursop tea can help people with advanced acute myeloid leukemia (AML) or multiple myeloma (MM) when other treatments have stopped working. It aims to see if the tea is safe and can reduce signs of the disease.
Camden, New JerseyAges 18 years+ - NCT07770126Recruiting
Stomach bacteria study for gastric conditions and precancer
This study looks for certain stomach bacteria (other than the common H. pylori) that might be linked to stomach diseases or early signs of cancer. If you have a stomach condition, your participation could help doctors understand these bacteria better.
EdegemAges 18 years+ - NCT07769892Recruiting
Blood and stool test for digestive tract cancer screening
This study is testing a new way to screen for cancers of the digestive tract using a simple blood and stool test. It is for people who are already scheduled to have a digestive tract endoscopy, and it may help find cancers earlier without extra invasive procedures.
Zhaoqing, GuangdongAges 45–74 - NCT07773870Recruiting
Cold weather exposure and heart healing after stent placement
This study looks at how living or working in cold regions affects heart recovery after a stent procedure. Participants will have heart imaging at the start and again 6 months later to see if cold exposure impacts heart function.
Beijing, Please Select An Option BelowAges 18–80 - NCT07770425Recruiting
Measuring lesion size during gastrointestinal endoscopy
This study tests a new way to measure the size of abnormal areas found during a routine endoscopy procedure. It may help doctors make more accurate measurements, which could improve diagnosis and treatment planning.
Montreal, QuebecAges 18 years+ - NCT07774845Recruiting
Blood fats and platelets research for blood clot risk
This study looks at how blood fats (lipids) interact with platelets to help understand blood clot risk and possible future treatments. It is for people over 40 without known heart or artery disease.
São Paulo, São PauloAges 40 years+
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,504 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.